Advanced search
Publication Cover
Infectious Diseases Volume 51, 2019 - Issue 11-12
Submit an article Journal homepage
426
Views
14
CrossRef citations to date
0
Altmetric
Letter to the Editor

Antimicrobial in vitro activities of ceftazidime-avibactam, meropenem-vaborbactam and plazomicin against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa – a pilot Bulgarian study

Encho SavovLaboratory of Microbiology, Department of Military Epidemiology and Hygiene, Military Medical Academy, Sofia, Bulgaria;
,
Angelina TrifonovaLaboratory of Microbiology, Department of Military Epidemiology and Hygiene, Military Medical Academy, Sofia, Bulgaria; Correspondence[email protected]
,
Krassimira KovachkaMultiprofile Hospital for Active Treatment, Samokov, Bulgaria;
,
Elena KjossevaLaboratory of Microbiology, Department of Military Epidemiology and Hygiene, Military Medical Academy, Sofia, Bulgaria;
&
Tanya StratevaDepartment of Medical Microbiology, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria
Pages 870-873 | Received 26 Jul 2019, Accepted 02 Aug 2019, Published online: 21 Aug 2019

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Elizabeth Palavecino & Abdullah Kilic. (2021) Characterization of carbapenem-resistant Pseudomonas aeruginosa in a university hospital, United States. Infectious Diseases 53:5, pages 396-398.
Read now
Carmen Antonia Sanches Ito, Larissa Bail, Lavinia Nery Villa Stangler Arend, Keite da Silva Nogueira & Felipe Francisco Tuon. (2021) The activity of ceftazidime/avibactam against carbapenem-resistant Pseudomonas aeruginosa. Infectious Diseases 53:5, pages 386-389.
Read now

Articles from other publishers (12)

Rongxin Liang, Dongxing Wang, Mingjin Hu, Yuxia Gu, Meijun Wang, Dan Hu, Mingan Zhu & Meng Wang. (2023) In vitro activity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam alone or in combination with polymyxin B against carbapenem resistant Acinetobacter baumannii. The Journal of Antibiotics.
Crossref
Chih-Hao Chen, Pin-Han Wu, Min-Chi Lu, Mao-Wang Ho & Po-Ren Hsueh. (2023) Geographic patterns of carbapenem-resistant, multi-drug-resistant and difficult-to-treat Acinetobacter baumannii in the Asia-Pacific region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020. International Journal of Antimicrobial Agents 61:2, pages 106707.
Crossref
Flora Cruz-López, Adrián Martínez-Meléndez, Licet Villarreal-Treviño, Rayo Morfín-Otero, Héctor Maldonado-Garza & Elvira Garza-González. (2022) Contamination of healthcare environment by carbapenem-resistant Acinetobacter baumannii. The American Journal of the Medical Sciences 364:6, pages 685-694.
Crossref
Sisi Zhen, Hui Wang & Sizhou Feng. (2022) Update of clinical application in ceftazidime–avibactam for multidrug-resistant Gram-negative bacteria infections. Infection 50:6, pages 1409-1423.
Crossref
Nicola Coppola, Alberto Enrico Maraolo, Lorenzo Onorato, Riccardo Scotto, Federica Calò, Luigi Atripaldi, Anna Borrelli, Antonio Corcione, Maria Giovanna De Cristofaro, Emanuele Durante-Mangoni, Amelia Filippelli, Gianluigi Franci, Maria Galdo, Gaspare Guglielmi, Pasquale Pagliano, Alessandro Perrella, Ornella Piazza, Marco Picardi, Rodolfo Punzi, Ugo Trama & Ivan Gentile. (2022) Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion. Antibiotics 11:9, pages 1263.
Crossref
Paolo Gaibani, Tommaso Giani, Federica Bovo, Donatella Lombardo, Stefano Amadesi, Tiziana Lazzarotto, Marco Coppi, Gian Maria Rossolini & Simone Ambretti. (2022) Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing. Antibiotics 11:5, pages 628.
Crossref
Elina Dobreva, Ivan Ivanov, Deyan Donchev, Krasimira Ivanova, Rumyana Hristova, Veselin Dobrinov, Veselin Dobrinov, Stefana Sabtcheva & Todor Kantardjiev. (2022) In vitro Investigation of Antibiotic Combinations against Multi- and Extensively Drug-Resistant Klebsiella pneumoniae. Open Access Macedonian Journal of Medical Sciences 10:B, pages 1308-1314.
Crossref
Joanna Krajewska & Agnieszka Ewa Laudy. (2021) The European Medicines Agency Approved the New Antibacterial Drugs – Response to the 2017 Who Report on the Global Problem of Multi-Drug Resistance. Postępy Mikrobiologii - Advancements of Microbiology 60:4, pages 249-264.
Crossref
Maryam Touhidinia, Fatemeh Sefid & Mozhgan Bidakhavidi. (2021) Design of a Multi-epitope Vaccine Against Acinetobacter baumannii Using Immunoinformatics Approach. International Journal of Peptide Research and Therapeutics 27:4, pages 2417-2437.
Crossref
Tanaya Bhowmick & Melvin P. Weinstein. (2020) Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections. Infectious Diseases and Therapy 9:4, pages 757-767.
Crossref
Yuhang Wang, Jin Wang, Rui Wang & Yun Cai. (2020) Resistance to ceftazidime–avibactam and underlying mechanisms. Journal of Global Antimicrobial Resistance 22, pages 18-27.
Crossref
Chih-Cheng Lai, Chi-Chung Chen & Hung-Jen Tang. (2019) Meropenem-Vaborbactam in the Treatment of Acute Bacterial Infections. Journal of Clinical Medicine 8:10, pages 1650.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.